novo glp-1 Nordisk's oral drug didn't work on Alzheimer's as hoped, but don't call it a failure Novo Nordisk launched an oral

Download this ready-made, high-value Bariatric GLP-1 Patient Meal Planning Education Packet today

Are you okay with a slower process, or do you want more immediate results

On why sales are underwhelming despite low pricing: it's rarely just cost

70% have obesity or are overweight 2 25% will have severe obesity by 2030 3 50% are interested in weight-loss drugs 4 Our Commitment to Responsible GLP-1 Care Nooms medical programs are designed and led by clinicians who share a safety-first philosophy

Accidental overdoses of the popular diabetes and obesity drug semaglutide, sold under the trade names Ozempic and Wegovy, are on the rise, according to reports

Beyond Insulin: Using Ozempic and Other Off-Label Drugs for Type 1 Diabetes GLP-1 Receptor Agonists More and more clinicians are using GLP-1s off-label in people with type 1 diabetes, particularly in those who also have obesity or high insulin requirements, says Mihail Zilbermint, MD, an associate professor of medicine at Johns Hopkins University School of Medicine and the chief of the division of endocrinology, diabetes, and metabolism at Suburban Hospital in Maryland